{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:49:28Z","timestamp":1791215368607,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:00:00Z","timestamp":1285200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:00:00Z","timestamp":1285200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/leu.2010.208","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T10:08:17Z","timestamp":1285236497000},"page":"2072-2079","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations"],"prefix":"10.1038","volume":"24","author":[{"given":"T","family":"Zenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Trbusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Smardova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Benner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Soussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Helfrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Heuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Denzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"H\u00e4be","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Malcikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kuglik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Oscier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ibbotson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pettitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"D\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the European Research Initiative on CLL (ERIC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,23]]},"reference":[{"key":"BFleu2010208_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","volume":"77","author":"AC Joerger","year":"2008","unstructured":"Joerger AC, Fersht AR . Structural biology of the tumor suppressor p53. Annu Rev Biochem 2008; 77: 557\u2013582.","journal-title":"Annu Rev Biochem"},{"key":"BFleu2010208_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ccr.2007.10.001","volume":"12","author":"T Soussi","year":"2007","unstructured":"Soussi T, Wiman KG . Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 2007; 12: 303\u2013312.","journal-title":"Cancer Cell"},{"key":"BFleu2010208_CR3","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/sj.onc.1210280","volume":"26","author":"T Soussi","year":"2007","unstructured":"Soussi T . p53 alterations in human cancer: more questions than answers. Oncogene 2007; 26: 2145\u20132156.","journal-title":"Oncogene"},{"key":"BFleu2010208_CR4","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","volume":"112","author":"T Zenz","year":"2008","unstructured":"Zenz T, Kr\u00f6ber A, Scherer K, Habe S, B\u00fchler A, Benner A et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood 2008; 112: 3322\u20133329.","journal-title":"Blood"},{"key":"BFleu2010208_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/leu.2008.274","volume":"23","author":"F Dicker","year":"2009","unstructured":"Dicker F, Herholz H, Schnittger S, Nakao A, Patten N, Wu L et al. The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype. Leukemia 2009; 23: 117\u2013124.","journal-title":"Leukemia"},{"key":"BFleu2010208_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1078-0432.CCR-08-1630","volume":"15","author":"D Rossi","year":"2009","unstructured":"Rossi D, Cerri M, Deambrogi C, Sozzi E, Cresta S, Rasi S et al. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. Clin Cancer Res 2009; 15: 995\u20131004.","journal-title":"Clin Cancer Res"},{"key":"BFleu2010208_CR7","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1182\/blood-2009-05-224071","volume":"114","author":"T Zenz","year":"2009","unstructured":"Zenz T, H\u00e4be S, Denzel T, Mohr J, Winkler D, B\u00fchler A et al. Detailed analysis of p53 pathway defects in fludarabine-refractory CLL: dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood 2009; 114: 2589\u20132597.","journal-title":"Blood"},{"key":"BFleu2010208_CR8","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1182\/blood-2009-07-234708","volume":"114","author":"J Malcikova","year":"2009","unstructured":"Malcikova J, Smardova J, Rocnova L, Tichy B, Kuglik P, Vranova V et al. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival and response to DNA damage. Blood 2009; 114: 5307\u20135314.","journal-title":"Blood"},{"key":"BFleu2010208_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/sj.leu.2404195","volume":"20","author":"M Trbusek","year":"2006","unstructured":"Trbusek M, Malcikova J, Smardova J, Kuhrova V, Mentzlova D, Francova H et al. Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. Leukemia 2006; 20: 1159\u20131161.","journal-title":"Leukemia"},{"key":"BFleu2010208_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/10428190902763533","volume":"50","author":"T Zenz","year":"2009","unstructured":"Zenz T, Mohr J, Edelmann J, Sarno A, Hoth P, Heuberger M et al. Treatment resistance in chronic lymphocytic leukemia: the role of the p53 pathway. Leuk Lymphoma 2009; 50: 510\u2013513.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2010208_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/sj.leu.2405002","volume":"22","author":"T Bromidge","year":"2008","unstructured":"Bromidge T, Johnson S, Howe D . Spectrum of p53 mutations in low-grade B-cell malignancies. Leukemia 2008; 22: 1071\u20131073.","journal-title":"Leukemia"},{"key":"BFleu2010208_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/10428199509056825","volume":"17","author":"EW Newcomb","year":"1995","unstructured":"Newcomb EW . P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leuk Lymphoma 1995; 17: 211\u2013221.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2010208_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/mc.2940140402","volume":"14","author":"EW Newcomb","year":"1995","unstructured":"Newcomb EW, el Rouby S, Thomas A . A unique spectrum of p53 mutations in B-cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies. Mol Carcinog 1995; 14: 227\u2013232.","journal-title":"Mol Carcinog"},{"key":"BFleu2010208_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/(SICI)1098-1004(1998)12:1<4::AID-HUMU2>3.0.CO;2-G","volume":"12","author":"M Prokocimer","year":"1998","unstructured":"Prokocimer M, Unger R, Rennert HS, Rotter V, Rennert G . Pooled analysis of p53 mutations in hematological malignancies. Hum Mutat 1998; 12: 4\u201318.","journal-title":"Hum Mutat"},{"key":"BFleu2010208_CR15","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1073\/pnas.92.9.3963","volume":"92","author":"JM Flaman","year":"1995","unstructured":"Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995; 92: 3963\u20133967.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2010208_CR16","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","volume":"85","author":"H Dohner","year":"1995","unstructured":"Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995; 85: 1580\u20131589.","journal-title":"Blood"},{"key":"BFleu2010208_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000050597","volume":"22","author":"J Smardova","year":"2001","unstructured":"Smardova J, Nemajerova A, Trbusek M, Vagunda V, Kovarik J . Rare somatic p53 mutation identified in breast cancer: a case report. Tumour Biol 2001; 22: 59\u201366.","journal-title":"Tumour Biol"},{"key":"BFleu2010208_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF03036739","volume":"8","author":"J Smardova","year":"2002","unstructured":"Smardova J, Pavlova S, Koukalova H . Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast. Pathol Oncol Res 2002; 8: 245\u2013251.","journal-title":"Pathol Oncol Res"},{"key":"BFleu2010208_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.onc.1200812","volume":"14","author":"F Waridel","year":"1997","unstructured":"Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P et al. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene 1997; 14: 163\u2013169.","journal-title":"Oncogene"},{"key":"BFleu2010208_CR20","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.molimm.2007.08.017","volume":"45","author":"J Malcikova","year":"2008","unstructured":"Malcikova J, Smardova J, Pekova S, Cejkova S, Kotaskova J, Tichy B et al. Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia. Mol Immunol 2008; 45: 1525\u20131529.","journal-title":"Mol Immunol"},{"key":"BFleu2010208_CR21","first-page":"16","volume":"82","author":"F Morabito","year":"1997","unstructured":"Morabito F, Filangeri M, Callea I, Sculli G, Callea V, Fracchiolla NS et al. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs. Haematologica 1997; 82: 16\u201320.","journal-title":"Haematologica"},{"key":"BFleu2010208_CR22","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","volume":"84","author":"T Watanabe","year":"1994","unstructured":"Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T et al. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 1994; 84: 3158\u20133165.","journal-title":"Blood"},{"key":"BFleu2010208_CR23","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1182\/blood-2007-09-112698","volume":"111","author":"C Saddler","year":"2008","unstructured":"Saddler C, Ouillette P, Kujawski L, Shangary S, Talpaz M, Kaminski M et al. Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia. Blood 2008; 111: 1584\u20131593.","journal-title":"Blood"},{"key":"BFleu2010208_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/humu.20395","volume":"27","author":"T Soussi","year":"2006","unstructured":"Soussi T, Rubio-Nevado JM, Ishioka C . MUT-TP53: a versatile matrix for TP53 mutation verification and publication. Hum Mutat 2006; 27: 1151\u20131154.","journal-title":"Hum Mutat"},{"key":"BFleu2010208_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1158\/1078-0432.CCR-05-0413","volume":"12","author":"T Soussi","year":"2006","unstructured":"Soussi T, Asselain B, Hamroun D, Kato S, Ishioka C, Claustres M . et al. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 2006; 12: 62\u201369.","journal-title":"Clin Cancer Res"},{"key":"BFleu2010208_CR26","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1182\/blood.V91.11.4342","volume":"91","author":"I Cordone","year":"1998","unstructured":"Cordone I, Masi S, Mauro FR, Soddu S, Morsilli O, Valentini T et al. p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood 1998; 91: 4342\u20134349.","journal-title":"Blood"},{"key":"BFleu2010208_CR27","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V82.11.3452.3452","volume":"82","author":"S el Rouby","year":"1993","unstructured":"el Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R et al. p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1\/MDR3 gene expression. Blood 1993; 82: 3452\u20133459.","journal-title":"Blood"},{"key":"BFleu2010208_CR28","first-page":"246","volume":"6","author":"P Fenaux","year":"1992","unstructured":"Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M et al. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 1992; 6: 246\u2013250.","journal-title":"Leukemia"},{"key":"BFleu2010208_CR29","first-page":"1342","volume":"8","author":"P Lepelley","year":"1994","unstructured":"Lepelley P, Preudhomme C, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P . Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia 1994; 8: 1342\u20131349.","journal-title":"Leukemia"},{"key":"BFleu2010208_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.cdd.4401194","volume":"10","author":"I Sturm","year":"2003","unstructured":"Sturm I, Bosanquet AG, Hermann S, Guner D, Dorken B, Daniel PT . Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy. Cell Death Differ 2003; 10: 477\u2013484.","journal-title":"Cell Death Differ"},{"key":"BFleu2010208_CR31","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","volume":"84","author":"E Wattel","year":"1994","unstructured":"Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervit I et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 1994; 84: 3148\u20133157.","journal-title":"Blood"},{"key":"BFleu2010208_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc1783","volume":"6","author":"T Soussi","year":"2006","unstructured":"Soussi T, Ishioka C, Claustres M, Beroud C . Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat Rev Cancer 2006; 6: 83\u201390.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2010208_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/humu.20114","volume":"25","author":"T Soussi","year":"2005","unstructured":"Soussi T, Kato S, Levy PP, Ishioka C . Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 2005; 25: 6\u201317.","journal-title":"Hum Mutat"},{"key":"BFleu2010208_CR34","doi-asserted-by":"publisher","first-page":"11927","DOI":"10.1073\/pnas.95.20.11927","volume":"95","author":"SN Rodin","year":"1998","unstructured":"Rodin SN, Rodin AS . Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells. Proc Natl Acad Sci USA 1998; 95: 11927\u201311932.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2010208_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/350429a0","volume":"350","author":"B Bressac","year":"1991","unstructured":"Bressac B, Kew M, Wands J, Ozturk M . Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429\u2013431.","journal-title":"Nature"},{"key":"BFleu2010208_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.2870040102","volume":"4","author":"C Caron de Fromentel","year":"1992","unstructured":"Caron de Fromentel C, Soussi T . TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 1992; 4: 1\u201315.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2010208_CR37","doi-asserted-by":"crossref","unstructured":"Zenz T, Eichhorst BF, Busch R, Denzel T, H\u00e4be S, Winkler D et al. TP53 mutation and survival in chronic lymphocytic leukaemia. JCO 2010, e-pub ahead of print 9 August 2010.","DOI":"10.1200\/JCO.2009.27.8762"},{"key":"BFleu2010208_CR38","first-page":"781","volume":"112","author":"S Stilgenbauer","year":"2008","unstructured":"Stilgenbauer S, Zenz T, Winkler D, Buhler A, Busch R, Fingerle-Rowson G et al. Genomic aberrations, VH mutation status and outcome after fludarabine and cyclophosphamide (FC) or FC plus rituximab (FCR) in the CLL8 Trial. ASH Annu Meeting Abstr 2008; 112: 781.","journal-title":"ASH Annu Meeting Abstr"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2010208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010208","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:30:32Z","timestamp":1648733432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,23]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFleu2010208"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.208","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,23]]},"assertion":[{"value":"17 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}